Elekta invites you to a Capital Markets Day in Crawley, UK, on November 14

Elekta invites you to a Capital Markets Day in Crawley, UK, on November 14 Stockholm 7 October 2003 The total world market for Elekta's products for radiation therapy for cancer amounts to between USD 1.5 and 2 billion and is estimated to be increasing by 5 to 10 percent annually. Elekta is the world's second largest manufacturer of radiation therapy equipment and these products make up approx. 70 percent of the company's net sales. In many markets, rapid growth is being fueled by demand for the new, more precise and accurate treatment methods. IMRT and the emerging field of image-guided radiation therapy (IGRT) are beginning to change the fundamental prerequisites for radiation treatment of cancer. Elekta has a long and extensive experience of IMRT and a leading position in IGRT through Elekta Synergytm, the first kilovolt-based system for diagnostic quality imaging of the patient during treatment. The accuracy that Elekta Synergytm provides, in combination with advanced technologies such as IMRT, may allow treating physicians to develop new and advanced methods for more aggressive radiation treatment of cancer. To further discuss these issues and to offer hands on experience of Elekta products as well as a factory tour, Elekta invites shareholders, investors, journalists and analysts to a Capital Markets Day at Elekta's facilities in Crawley, south of London. Date: Friday November 14, 2003 Time: The program will start at 10.45 GMT and continue until 15.00. Location: Elekta Limited, Linac House, Fleming Way, Crawley, West Sussex (Close to Gatwick Airport, halfway between London and Brighton.) Presenters: Volker Stieber, Executive VP - Technology Development & Operations Dee Mathieson, Vice President, Product Manager for Elekta Synergytm Peter Hart, Vice President, Head of Elekta Research & Development If you want to participate, please send an e-mail or fax (including name, company, function and contact details) to Peter Ejemyr, Group VP Corporate Communications, e-mail: peter.ejemyr@elekta.com, fax +46 8 411 4546. For planning purposes, we need your response no later than Friday 31 October. Looking forward to see you in Crawley! Best regards, Peter Ejemyr, Group VP Corporate Communications Tel: +46 8 58725400 ------------------------------------------------------------ Denna information skickades av Waymaker http://www.waymaker.se Följande filer finns att ladda ned: http://www.waymaker.net/bitonline/2003/10/07/20031007BIT00420/wkr0001.doc http://www.waymaker.net/bitonline/2003/10/07/20031007BIT00420/wkr0002.pdf

Om oss

Under nästan fem årtionden har Elekta varit ledare inom precisionsbaserad strålbehandling. Våra nästan 4000 anställda över hela världen är engagerade för att möjliggöra att alla i världen med cancer har tillgång till - och fördel av - mer precis, individanpassad strålbehandling. Elekta har sitt huvudkontor i Stockholm och är noterat på Nasdaq Stockholm. Besök elekta.com eller följ @Elekta på Twitter.

Prenumerera

Dokument & länkar